Susceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains

scientific article published on February 1, 1991

Susceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JVI.65.2.1035-1040.1991
P953full work available at URLhttp://jvi.asm.org/cgi/content/abstract/65/2/1035
https://europepmc.org/articles/PMC239854
https://europepmc.org/articles/PMC239854?pdf=render
https://journals.asm.org/doi/pdf/10.1128/jvi.65.2.1035-1040.1991
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1846183/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1846183/pdf/?tool=EBI
P932PMC publication ID239854
P698PubMed publication ID1846183

P2093author name stringS. Goldfarb
C. Waltenbaugh
B. Jubelt
R. P. Oates
S. L. Ropka
P2860cites workThe epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearanceQ28235201
Some Contributions of the HL-A Complex to the Genetics of Human DiseasesQ33465540
A twin-family study of susceptibility to poliomyelitisQ35251432
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strainsQ36895904
Lack of neutralizing antibodies to caprine arthritis-encephalitis lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosisQ36911729
Quantitation of enterovirus 70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strainsQ38479627
Genetically controlled resistance to virus infections of the central nervous systemQ39503190
HLA-A, -B, and -D Antigens in Paralytic PoliomyelitisQ39556365
Immunosuppression: a means to assess the role of the immune response in acute virus infectionsQ40015629
African swine fever: a reassessment.Q40323239
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strainsQ41337544
Demyelination induced by Theiler's virus: influence of the H-2 haplotypeQ41362044
Study of the HLA antigen in Arab children with paralytic poliomyelitisQ41449906
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivityQ41489563
Differential resistance to paralytic poliomyelitis controlled by histocompatibility leukocyte antigensQ42668895
Pathogenesis of human poliovirus infection in mice. II. Age-dependency of paralysis.Q44010294
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patientsQ44255828
Cell-mediated immune responses to poliovirus II. Survey of delayed hypersensitivity and T-cell proliferative responses in inbred mouse strainsQ44807444
Coxsackievirus B3 murine myocarditis: wide pathologic spectrum in genetically defined inbred strainsQ45007013
Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice.Q45794739
The intercellular gaps of the neuropil as possible pathways for virus spread in viral encephalomyelitidesQ45811244
An Association of HL-A3 and HL-A7 with Paralytic PoliomyelitisQ47857933
The distribution within the brain of ferritin injected into cerebrospinal fluid compartments. II. Parenchymal distribution.Q51248292
Abortive poliomyelitis or minor illness as a clue to genetic susceptibilityQ67420977
Cell-mediated immune responses to poliovirus. I. Conditions for induction, characterization of effector cells, and cross-reactivity between serotypes for delayed hypersensitivity and T cell proliferative responsesQ69337691
Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous systemQ69338011
Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of miceQ70128440
Lansing poliovirus infection in mice: antibody demonstrable by enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation but not by neutralizationQ70161761
Poliovirus infection of cyclophosphamide- treated mice results in persistence and late paralysis: I. Clinical, pathologic, and immunologic studiesQ70193407
Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis: II. Virologic studiesQ70193410
Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studiesQ72850426
Prolonged intracerebral infection with poliovirus in asymptomatic miceQ72901003
Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groupsQ75878252
An outbreak of poliomyelitis in Canadian Eskimos in wintertimeQ80615011
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
microbiologyQ7193
PoliovirusQ70923324
P304page(s)1035-40
P577publication date1991-02-01
P1433published inJournal of VirologyQ1251128
P1476titleSusceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains
P478volume65

Reverse relations

cites work (P2860)
Q36650977A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.
Q34316914Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis.
Q35845137Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Q27469670Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus
Q45878942Genetic characterization of sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract
Q48746513Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo.
Q33918627Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation